ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for central nervous system disorders, today announced it
will release results for the third quarter of 2010, on Wednesday, November 3, 2010, before the market
opens. A full text copy of the release will be disseminated at that
time.
Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer, will host a conference call
to discuss the results at 10:00 AM ET
on Wednesday, November 3, 2010.
To participate in the conference call, dial the appropriate
number below shortly before the 10:00
AM start time and ask for the Vanda Pharmaceuticals
conference call hosted by Dr. Polymeropoulos.
|
The
teleconference dial-in numbers are as follows:
|
|
|
Domestic
callers 1-866-730-5768
|
|
|
International callers
1-857-350-1592
|
|
|
Participant
Passcode 11659354
|
|
|
The conference call will be broadcast simultaneously and
archived on the Company's website, www.vandapharma.com. Investors
should go to the website at least 15 minutes early to register,
download, and install any necessary audio software.
A replay of the call will be available on Wednesday, November 3, 2010, beginning at
1:00 PM ET and will be accessible
until Wednesday, November 10, 2010,
at 5:00 PM ET. The replay call-in
number is 1-888-286-8010 for domestic callers and 1-617-801-6888
for international callers. The access number is 14475834.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
central nervous system disorders. For more on Vanda
Pharmaceuticals Inc., please visit http://www.vandapharma.com.
CONTACT: Cristina Murphy,
Communications Manager of Vanda Pharmaceuticals Inc.,
+1-240-599-4500
SOURCE Vanda Pharmaceuticals Inc.
Copyright . 28 PR Newswire